Vor Biopharma Inc.
USD18.60
+2.50 (+15.53%)
CEO
Jean-Paul Kress
IPO Date
2021-02-05
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$16.10
Prev. Close
$16.10
Day Low
$16.10
Day High
$18.76
52W Low
$6.50
52W High
$65.80
Market Cap
$0.13B
Volume
2.79M
| 57,162 |
| $14.09 |
| 12 Jun 2026 | Namouni Fouad | director | A-Award | Acquired | 56,549 | $14.09 |
| 12 Jun 2026 | Joustra Wouter | director | A-Award | Acquired | 57,162 | $14.09 |
| 12 Jun 2026 | Kalir Erez | director | A-Award | Acquired | 57,162 | $14.09 |
| 12 Jun 2026 | Cumbo Alexander | director | A-Award | Acquired | 56,345 | $14.09 |
| 12 Jun 2026 | Beckman Daniella | director | A-Award | Acquired | 53,283 | $14.09 |
| 12 Jun 2026 | Levin Andrew David | director | A-Award | Acquired | 57,162 | $14.09 |
| 24 Apr 2026 | RA CAPITAL MANAGEMENT, L.P. | director, 10 percent owner: | S-Sale | Disposed | 165,150 | $15.77 |
| 21 Apr 2026 | RA CAPITAL MANAGEMENT, L.P. | director, 10 percent owner: | S-Sale | Disposed | 458,411 | $16.28 |